(Q39472095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

gram-positive bacteria

0 references

Gram-negative bacteria

0 references

author name string

G A Pankuch

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M R Jacobs

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P C Appelbaum

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

2574-2575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms

31 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

The post-antibiotic sub-MIC effect in vitro and in vivo

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

The post-antibiotic effect

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

Antibacterial properties of AM-1155, a new 8-methoxy quinolone.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89526

Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10508050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10508050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10508050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.43.10.2574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10508050%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

10508050

1 reference